Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
- PMID: 29479548
- PMCID: PMC5804852
- DOI: 10.1093/ofid/ofy010
Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
Abstract
Background: The microbial etiology of community-acquired pneumonia (CAP) is often unclear in clinical practice, and previous studies have produced variable results. Population-based studies examining etiology and incidence are lacking. This study examined the incidence and etiology of CAP requiring hospitalization in a population-based cohort as well as risk factors and outcomes for specific etiologies.
Methods: Consecutive admissions due to CAP in Reykjavik, Iceland were studied. Etiologic testing was performed with cultures, urine-antigen detection, and polymerase chain reaction analysis of airway samples. Outcomes were length of stay, intensive care unit admission, assisted ventilation, and mortality.
Results: The inclusion rate was 95%. The incidence of CAP requiring hospitalization was 20.6 cases per 10000 adults/year. A potential pathogen was detected in 52% (164 of 310) of admissions and in 74% (43 of 58) with complete sample sets. Streptococcuspneumoniae was the most common pathogen (61 of 310, 20%; incidence: 4.1/10000). Viruses were identified in 15% (47 of 310; incidence: 3.1/10000), Mycoplasmapneumoniae were identified in 12% (36 of 310; incidence: 2.4/10000), and multiple pathogens were identified in 10% (30 of 310; incidence: 2.0/10000). Recent antimicrobial therapy was associated with increased detection of M pneumoniae (P < .001), whereas a lack of recent antimicrobial therapy was associated with increased detection of S pneumoniae (P = .02). Symptoms and outcomes were similar irrespective of microbial etiology.
Conclusions: Pneumococci, M pneumoniae, and viruses are the most common pathogens associated with CAP requiring hospital admission, and they all have a similar incidence that increases with age. Symptoms do not correlate with specific agents, and outcomes are similar irrespective of pathogens identified.
Keywords: Mycoplasma pneumoniae; Streptococcus pneumoniae; community-acquired pneumonia; etiology; incidence.
Similar articles
-
Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.Chest. 2007 Mar;131(3):779-787. doi: 10.1378/chest.06-1800. Chest. 2007. PMID: 17356093
-
Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan.Respir Med. 2005 Sep;99(9):1079-86. doi: 10.1016/j.rmed.2005.02.026. Epub 2005 Apr 18. Respir Med. 2005. PMID: 16085210
-
Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia.Lung India. 2018 Mar-Apr;35(2):108-115. doi: 10.4103/lungindia.lungindia_288_17. Lung India. 2018. PMID: 29487244 Free PMC article.
-
Burden of community-acquired pneumonia in North American adults.Postgrad Med. 2010 Mar;122(2):130-41. doi: 10.3810/pgm.2010.03.2130. Postgrad Med. 2010. PMID: 20203464 Review.
-
[Community-acquired pneumonia: prospective study of 101 adult, immunocompetent patients for 1 year].Enferm Infecc Microbiol Clin. 1993 Dec;11(10):525-30. Enferm Infecc Microbiol Clin. 1993. PMID: 8142501 Review. Spanish.
Cited by
-
Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database.Front Pharmacol. 2024 Sep 13;15:1402386. doi: 10.3389/fphar.2024.1402386. eCollection 2024. Front Pharmacol. 2024. PMID: 39346559 Free PMC article.
-
Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns.Pneumonia (Nathan). 2022 May 5;14(1):4. doi: 10.1186/s41479-022-00096-z. Pneumonia (Nathan). 2022. PMID: 35509063 Free PMC article. Review.
-
Gram Stain and Culture of Sputum Samples Detect Only Few Pathogens in Community-Acquired Lower Respiratory Tract Infections: Secondary Analysis of a Randomized Controlled Trial.Diagnostics (Basel). 2023 Feb 8;13(4):628. doi: 10.3390/diagnostics13040628. Diagnostics (Basel). 2023. PMID: 36832116 Free PMC article.
-
Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management.Medicina (Kaunas). 2025 Jun 11;61(6):1078. doi: 10.3390/medicina61061078. Medicina (Kaunas). 2025. PMID: 40572766 Free PMC article.
-
The CREPE Score: A Predictive Tool for Third-Generation Cephalosporin-Resistant Enterobacterales Pneumonia in Community Settings.Infect Drug Resist. 2023 Jun 27;16:4159-4169. doi: 10.2147/IDR.S417863. eCollection 2023. Infect Drug Resist. 2023. PMID: 37396065 Free PMC article.
References
-
- Troeger C, Forouzanfar M, Rao PC, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 2017; 17:1133–61. - PMC - PubMed
-
- Marston BJ, Plouffe JF, File TM Jr et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157:1709–18. - PubMed
-
- Ishida T, Hashimoto T, Arita M et al. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998; 114:1588–93. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous